If you or a loved one has been diagnosed with uveal (ocular) melanoma, there is a chance that the cancer will spread to another part of your body. This is called metastatic uveal melanoma.

Until recently, uveal melanoma was a disease that was poorly ... In some people, there may be no symptoms, but it can be picked up by routine eye tests. Some experience issues with their vision ...

Over 5 years of surveillance, just 4% of patients with low-risk uveal melanoma developed metastasis, according to a retrospective cohort study published online ahead of print in Ophthalmology. The ...

Search for other works by this author on: ...

The ZAP-X® system provides a non-invasive, single-session treatment for uveal melanoma, achieving tumor control rates similar to other radiotherapy methods. SRS offers advantages such as globe-sparing ...

This technology was utilized to treat a patient with uveal melanoma. A relatively new technology, The ZAP-X system (Zap Surgical Systems Inc., San Carlos, CA), described by investigators as a ...

Following a recent Type D meeting with the FDA, a phase 3 clinical trial design for darovasertib in primary uveal melanoma has been announced. A successful Type D meeting between the FDA and IDEAYA ...

IDE196 has been granted Breakthrough Therapy designation for neoadjuvant treatment of primary uveal melanoma, highlighting its potential in addressing unmet medical needs. The FDA's Breakthrough ...

Uveal melanoma (UM) is a rare orphan disease with significant unmet clinical need. Unlike cutaneous melanoma, UM has a low tumor mutational burden and a highly immunosuppressive microenvironment, ...

The objectives of ocular treatment are to prevent metastatic spread, and if possible, to conserve the eye and useful vision. Eye-conserving therapeutic modalities include various forms of ...